Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Emerging Infectious Diseases|September 2, 2008
Popular and scientific attitudes regarding pandemic influenzaPeter Doshi
Lancet (London, England)|March 6, 2007
Estimation of death rates from pandemic influenzaPeter Doshi
JAMA Internal Medicine|April 5, 2013
Influenza vaccines: time for a rethinkPeter Doshi
BMJ (Clinical Research Ed.)|August 8, 2014
US incentive scheme for neglected diseases: a good idea gone wrong?Peter Doshi
BMJ (Clinical Research Ed.)|May 18, 2013
Influenza: marketing vaccine by marketing diseasePeter Doshi
American Journal of Public Health|April 3, 2008
Trends in recorded influenza mortality: United States, 1900-2004Peter Doshi
BMJ (Clinical Research Ed.)|June 14, 2015
FDA drug summaries: a simplification too far?Peter Doshi
BMJ (Clinical Research Ed.)|November 11, 2006
Influenza vaccination: policy versus evidence: policy is in the leadPeter Doshi
BMJ (Clinical Research Ed.)|July 25, 2015
21st century cures: is US medicines bill a colossal mistake?Peter Doshi
BMJ (Clinical Research Ed.)|September 18, 2015
No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibilityPeter Doshi
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Emerging Infectious Diseases|September 2, 2008
Popular and scientific attitudes regarding pandemic influenzaPeter Doshi
Lancet (London, England)|March 6, 2007
Estimation of death rates from pandemic influenzaPeter Doshi
JAMA Internal Medicine|April 5, 2013
Influenza vaccines: time for a rethinkPeter Doshi
BMJ (Clinical Research Ed.)|August 8, 2014
US incentive scheme for neglected diseases: a good idea gone wrong?Peter Doshi
BMJ (Clinical Research Ed.)|May 18, 2013
Influenza: marketing vaccine by marketing diseasePeter Doshi
American Journal of Public Health|April 3, 2008
Trends in recorded influenza mortality: United States, 1900-2004Peter Doshi
BMJ (Clinical Research Ed.)|June 14, 2015
FDA drug summaries: a simplification too far?Peter Doshi
BMJ (Clinical Research Ed.)|November 11, 2006
Influenza vaccination: policy versus evidence: policy is in the leadPeter Doshi
BMJ (Clinical Research Ed.)|July 25, 2015
21st century cures: is US medicines bill a colossal mistake?Peter Doshi
BMJ (Clinical Research Ed.)|September 18, 2015
No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibilityPeter Doshi
Pageof 15